Nanox to Participate in Upcoming Investor Conference in September 2024
Nanox (Nasdaq: NNOX), an innovative medical imaging technology company, has announced its participation in the Cantor Fitzgerald Global Healthcare Conference in September 2024. This investor conference provides an opportunity for Nanox management to showcase their cutting-edge medical imaging solutions and engage with potential investors and industry professionals.
The participation in this prestigious healthcare conference underscores Nanox's commitment to expanding its market presence and fostering relationships within the investment community. As a company at the forefront of medical imaging technology, Nanox's attendance at the conference may offer valuable insights into their latest developments, market strategies, and future growth prospects.
Nanox (Nasdaq: NNOX), un'azienda innovativa nel settore della tecnologia di imaging medico, ha annunciato la sua partecipazione al Cantor Fitzgerald Global Healthcare Conference nel settembre 2024. Questa conferenza per investitori offre l'opportunità alla direzione di Nanox di presentare le loro soluzioni all'avanguardia in fatto di imaging medico e interagire con potenziali investitori e professionisti del settore.
La partecipazione a questa prestigiosa conferenza nel settore sanitario sottolinea l'impegno di Nanox nell'espandere la propria presenza sul mercato e nel favorire relazioni all'interno della comunità degli investimenti. Essendo un'azienda all'avanguardia nella tecnologia dell'imaging medico, la presenza di Nanox alla conferenza potrebbe offrire preziose intuizioni sui loro ultimi sviluppi, strategie di mercato e prospettive di crescita futura.
Nanox (Nasdaq: NNOX), una empresa innovadora en tecnología de imagen médica, ha anunciado su participación en la Cantor Fitzgerald Global Healthcare Conference en septiembre de 2024. Esta conferencia para inversores brinda la oportunidad a la dirección de Nanox de mostrar sus soluciones de imagen médica de vanguardia e interactuar con potenciales inversores y profesionales del sector.
La participación en esta prestigiosa conferencia de salud subraya el compromiso de Nanox de ampliar su presencia en el mercado y fomentar relaciones dentro de la comunidad inversora. Como una empresa a la vanguardia de la tecnología de imagen médica, la asistencia de Nanox a la conferencia puede proporcionar valiosos conocimientos sobre sus últimos desarrollos, estrategias de mercado y perspectivas de crecimiento futuro.
Nanox (Nasdaq: NNOX), 혁신적인 의료 영상 기술 회사가 2024년 9월에 열리는 칸토르 피츠제랄드 글로벌 헬스케어 컨퍼런스에 참가한다고 발표했습니다. 이 투자자 회의는 Nanox 경영진이 최첨단 의료 영상 솔루션을 선보이고 잠재 투자자 및 업계 전문가와 소통할 수 있는 기회를 제공합니다.
이 권위 있는 의료 회의에 참여하는 것은 Nanox의 시장 존재감을 확대하고 투자 커뮤니티와의 관계를 발전시키겠다는 의지를 강조합니다. 의료 영상 기술의 최전선에 있는 기업으로서 Nanox의 회의 참여는 최신 개발, 시장 전략 및 미래 성장 전망에 대한 귀중한 통찰력을 제공할 수 있습니다.
Nanox (Nasdaq: NNOX), une entreprise innovante dans le domaine de la technologie d'imagerie médicale, a annoncé sa participation à la Cantor Fitzgerald Global Healthcare Conference en septembre 2024. Cette conférence pour investisseurs offre à la direction de Nanox l’opportunité de présenter ses solutions d’imagerie médicale de pointe et d’échanger avec des investisseurs potentiels et des professionnels du secteur.
La participation à cette prestigieuse conférence sur la santé souligne l'engagement de Nanox à élargir sa présence sur le marché et à développer des relations au sein de la communauté d'investissement. En tant qu'entreprise à la pointe de la technologie d'imagerie médicale, la présence de Nanox à la conférence pourrait offrir des perspectives précieuses sur ses derniers développements, ses stratégies de marché et ses perspectives de croissance future.
Nanox (Nasdaq: NNOX), ein innovatives Unternehmen im Bereich der medizinischen Bildgebungstechnologie, hat seine Teilnahme an der Cantor Fitzgerald Global Healthcare Conference im September 2024 bekannt gegeben. Diese Investorenkonferenz bietet der Nanox-Geschäftsführung die Möglichkeit, ihre hochmodernen medizinischen Bildgebungslösungen vorzustellen und mit potenziellen Investoren und Fachleuten der Branche zu interagieren.
Die Teilnahme an dieser renommierten Gesundheitskonferenz unterstreicht Nanox' Engagement, ihre Marktpräsenz auszubauen und Beziehungen innerhalb der Investmentgemeinschaft zu fördern. Als ein Unternehmen, das an der Spitze der medizinischen Bildgebungstechnologie steht, könnte die Teilnahme von Nanox an der Konferenz wertvolle Einblicke in ihre neuesten Entwicklungen, Marktstrategien und zukünftigen Wachstumsprognosen bieten.
- None.
- None.
PETACH TIKVA, Israel, Sept. 10, 2024 (GLOBE NEWSWIRE) -- NANO-X IMAGING LTD (“Nanox” or the “Company,” Nasdaq: NNOX), an innovative medical imaging technology company, today announced that Company management will participate in an investor conference in the month of September 2024:
- Cantor Fitzgerald Global Healthcare Conference
About Cantor Fitzgerald Global Healthcare Conference
Nanox’s Chief Executive Officer and Acting Chairman, Erez Meltzer, and Chief Financial Officer, Ran Daniel, will engage in a fireside chat at the Cantor Fitzgerald Global Healthcare Conference, which will be held at the InterContinental New York Barclay Hotel in New York City on September 17-19, 2024.
The fireside chat is scheduled for Wednesday, September 18 at 10:55 am Eastern Time, and will be accessible via a live webcast here. Interested parties may also access the link to the live audio webcast on the Investor Relations section of the Company’s website. The webcast replay will be available after the conclusion of the fireside chat.
About Nanox
Nanox (NASDAQ: NNOX) is focused on applying its proprietary medical imaging technology and solutions to make diagnostic medicine more accessible and affordable across the globe. Nanox’s vision is to increase access, reduce costs and enhance the efficiency of routine medical imaging technology and processes, in order to improve early detection and treatment, which Nanox believes is key to helping people achieve better health outcomes, and, ultimately, to save lives. The Nanox ecosystem includes Nanox.ARC— a multi-source Digital Tomosynthesis system that is cost-effective and user-friendly; an AI-based suite of algorithms that augment the readings of routine CT imaging to highlight early signs often related to chronic disease (Nanox.AI); a cloud-based infrastructure (Nanox.CLOUD); and a proprietary decentralized marketplace, through Nanox’s subsidiary, USARAD Holdings Inc., that provides remote access to radiology and cardiology experts; and a comprehensive teleradiology services platform (Nanox.MARKETPLACE). Together, Nanox’s products and services create a worldwide, innovative, and comprehensive solution that connects medical imaging solutions, from scan to diagnosis. For more information, please visit www.nanox.vision. 
FAQ
What investor conference will Nanox (NNOX) participate in during September 2024?
Why is Nanox's (NNOX) participation in the Cantor Fitzgerald Global Healthcare Conference significant?
What type of company is Nanox (NNOX)?
When did Nanox (NNOX) announce their participation in the upcoming investor conference?
